(Q33864253)

29 July 2017

ABT-431, a D1 receptor agonist prodrug, has efficacy in Parkinson's disease (English)

1 reference

29 July 2017

1 reference

Rascol O

1

1 reference

29 July 2017

Blin O

2

1 reference

29 July 2017

Thalamas C

3

1 reference

29 July 2017

Descombes S

4

1 reference

29 July 2017

Soubrouillard C

5

1 reference

29 July 2017

Azulay P

6

1 reference

29 July 2017

Fabre N

7

1 reference

29 July 2017

Viallet F

8

1 reference

29 July 2017

Lafnitzegger K

9

1 reference

29 July 2017

Wright S

10

1 reference

29 July 2017

Carter JH

11

1 reference

29 July 2017

Nutt JG

12

1 reference

29 July 2017

1 June 1999

1 reference

29 July 2017

1 reference

29 July 2017

45

1 reference

29 July 2017

6

1 reference

29 July 2017

736-741

1 reference

Multiple receptors for dopamine

29 July 2017

1 reference

https://api.crossref.org/works/10.1002%2F1531-8249%28199906%2945%3A6%3C736%3A%3AAID-ANA7%3E3.0.CO%3B2-F

A-77636: a potent and selective dopamine D1 receptor agonist with antiparkinsonian activity in marmosets

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8249%28199906%2945%3A6%3C736%3A%3AAID-ANA7%3E3.0.CO%3B2-F

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8249%28199906%2945%3A6%3C736%3A%3AAID-ANA7%3E3.0.CO%3B2-F

Potential therapeutic use of the selective dopamine D1 receptor agonist, A-86929: an acute study in parkinsonian levodopa-primed monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8249%28199906%2945%3A6%3C736%3A%3AAID-ANA7%3E3.0.CO%3B2-F

The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8249%28199906%2945%3A6%3C736%3A%3AAID-ANA7%3E3.0.CO%3B2-F

Parkinsonism: onset, progression, and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8249%28199906%2945%3A6%3C736%3A%3AAID-ANA7%3E3.0.CO%3B2-F

Levodopa-induced dyskinesia: review, observations, and speculations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8249%28199906%2945%3A6%3C736%3A%3AAID-ANA7%3E3.0.CO%3B2-F

Suppression of dyskinesias in advanced Parkinson's disease. II. Increasing daily clozapine doses suppress dyskinesias and improve parkinsonism symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8249%28199906%2945%3A6%3C736%3A%3AAID-ANA7%3E3.0.CO%3B2-F

10.1002/1531-8249(199906)45:6<736::AID-ANA7>3.0.CO;2-F

21 January 2018

Identifiers

DOI

1 reference

29 July 2017

1 reference